These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1316305

  • 1. Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.
    Hawthorne AB, Boughton-Smith NK, Whittle BJ, Hawkey CJ.
    Gut; 1992 Apr; 33(4):513-7. PubMed ID: 1316305
    [Abstract] [Full Text] [Related]

  • 2. Characterization of leukotriene B4 synthesis in canine polymorphonuclear leukocytes.
    Amalsadvala TM, Vaughn DM.
    Prostaglandins Leukot Essent Fatty Acids; 1992 Apr; 45(4):283-8. PubMed ID: 1318548
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
    Tateson JE, Randall RW, Reynolds CH, Jackson WP, Bhattacherjee P, Salmon JA, Garland LG.
    Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
    [Abstract] [Full Text] [Related]

  • 4. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.
    Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Ito K, Toyota T.
    Scand J Gastroenterol; 1995 Jan; 30(1):44-9. PubMed ID: 7701249
    [Abstract] [Full Text] [Related]

  • 5. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.
    Boughton-Smith NK, Whittle BJ.
    Br J Pharmacol; 1988 Sep; 95(1):155-62. PubMed ID: 3146394
    [Abstract] [Full Text] [Related]

  • 6. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
    Schmidt C, Baumeister B, Kipnowski J, Schiermeyer-Dunkhase B, Vetter H.
    Hepatogastroenterology; 1996 Sep; 43(12):1508-12. PubMed ID: 8975956
    [Abstract] [Full Text] [Related]

  • 7. The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects.
    Sampson AP, Evans JM, Garland LG, Piper PJ, Costello JF.
    Pulm Pharmacol; 1990 Sep; 3(3):111-9. PubMed ID: 1966905
    [Abstract] [Full Text] [Related]

  • 8. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM, Spruce KE, Crawley GC, Walker ER, Foster SJ.
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [Abstract] [Full Text] [Related]

  • 9. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
    Lee E, Lindo T, Jackson N, Meng-Choong L, Reynolds P, Hill A, Haswell M, Jackson S, Kilfeather S.
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
    [Abstract] [Full Text] [Related]

  • 10. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
    Spaethe SM, Snyder DW, Pechous PA, Clarke T, VanAlstyne EL.
    Biochem Pharmacol; 1992 Jan 22; 43(2):377-82. PubMed ID: 1310855
    [Abstract] [Full Text] [Related]

  • 11. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
    Hillingsø J, Kjeldsen J, Laursen LS, Lauritsen K, von Spreckelsen S, Depré M, Friedman BS, Malmström K, Shingo S, Bukhave K.
    Clin Pharmacol Ther; 1995 Mar 22; 57(3):335-41. PubMed ID: 7697951
    [Abstract] [Full Text] [Related]

  • 12. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
    Sharon P, Stenson WF.
    Gastroenterology; 1984 Mar 22; 86(3):453-60. PubMed ID: 6319219
    [Abstract] [Full Text] [Related]

  • 13. Effect of BI-L-239, A-64077 and MK-886 on leukotriene B4 synthesis by chopped guinea pig lung and on antigen-induced tracheal contraction in vitro.
    Noonan TC, Jamieson-Leclercq T, Desai SN.
    Prostaglandins; 1992 Dec 22; 44(6):543-54. PubMed ID: 1335586
    [Abstract] [Full Text] [Related]

  • 14. The effect of a selective 5-lipoxygenase inhibitor, zileuton, on tissue damage in acute colonic inflammation in rats.
    Zarif A, Eiznhamer D, Callaghan C, Doria MI, Broutman L, Keshavarzian A.
    Inflammation; 1996 Jun 22; 20(3):217-27. PubMed ID: 8796377
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
    Fukuda T, Numao T, Akutsu I, Toda M, Motojima S, Makino S.
    Arzneimittelforschung; 1995 Sep 22; 45(9):1002-4. PubMed ID: 7488299
    [Abstract] [Full Text] [Related]

  • 16. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.
    Kimble E, Kowalski T, White D, Raychauduri A, Pastor G, Chertock H, Lee W, Neale R, Hamdan A, Wasley J.
    Agents Actions; 1991 Sep 22; 34(1-2):125-8. PubMed ID: 1665286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.